Clinical Trial Update: Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT411 [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of BNT411 in solid tumors and extensive-stage small cell lung cancer reported safety, pharmacokinetics, pharmacodynamics, and preliminary effica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Solid Tumor

Drugs mentioned

• BNT411

Snippet

Sponsor: BioNTech SE | Conditions: Solid Tumor, Extensive-stage Small Cell Lung Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2025-03-18